Award
Delivery Order #SPE2DR26FA7H5
AmerisourceBergen Awarded Pharmaceutical Delivery Order for Novolog Vials
Buyer
Defense Logistics Agency
Award Amount
$1,160.24
Ceiling
$1,160.24
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Feb 27, 2026
Identifier
SPE2DR26FA7H5
NAICS
424210
This award is a delivery order contract, recently executed under an existing Indefinite Delivery Vehicle with AmerisourceBergen Drug Corporation, a prominent pharmaceutical distributor. The contract concerns the procurement of Novolog insulin in 100 unit/mL vials of 10 mL size, a vital pharmaceutical product used in diabetes treatment. It supports federal healthcare services by ensuring the timely and reliable supply of essential medications. The scope of work includes the delivery of specified pharmaceutical vials at the designated location in Conshohocken, Pennsylvania, within a short time frame. This delivery order falls under a long-term contract that AmerisourceBergen holds, which enhances medication availability and distribution efficiency for federal agencies. There is no specific information indicating whether this delivery order was awarded competitively or as a sole source. The award date and period of performance occur over a brief interval in early 2026, reflecting a focused and timely fulfillment of the order. The contract leverages the broader umbrella of a federal supply schedule agreement, promoting streamlined pharmaceutical procurement for government health programs.
Description
4570971093!NOVOLOG 100 UNIT/ML VIAL 10ML